Cargando…

Plant-Based Drugs and Vaccines for COVID-19

The coronavirus SARS-CoV-2 has turned our own health and the world economy upside down. While several vaccine candidates are currently under development, antivirals with the potential to limit virus transmission or block infection are also being explored. Plant production platforms are being used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmood, Nasir, Nasir, Sarah Bushra, Hefferon, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823519/
https://www.ncbi.nlm.nih.gov/pubmed/33396667
http://dx.doi.org/10.3390/vaccines9010015
_version_ 1783639854760853504
author Mahmood, Nasir
Nasir, Sarah Bushra
Hefferon, Kathleen
author_facet Mahmood, Nasir
Nasir, Sarah Bushra
Hefferon, Kathleen
author_sort Mahmood, Nasir
collection PubMed
description The coronavirus SARS-CoV-2 has turned our own health and the world economy upside down. While several vaccine candidates are currently under development, antivirals with the potential to limit virus transmission or block infection are also being explored. Plant production platforms are being used to generate vaccines and antiviral proteins inexpensively and at mass scale. The following review discusses the biology and origins of the current coronavirus pandemic, and describes some of the conventional, synthetic, and plant-based approaches to address the challenge that it presents to our way of life.
format Online
Article
Text
id pubmed-7823519
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78235192021-01-24 Plant-Based Drugs and Vaccines for COVID-19 Mahmood, Nasir Nasir, Sarah Bushra Hefferon, Kathleen Vaccines (Basel) Review The coronavirus SARS-CoV-2 has turned our own health and the world economy upside down. While several vaccine candidates are currently under development, antivirals with the potential to limit virus transmission or block infection are also being explored. Plant production platforms are being used to generate vaccines and antiviral proteins inexpensively and at mass scale. The following review discusses the biology and origins of the current coronavirus pandemic, and describes some of the conventional, synthetic, and plant-based approaches to address the challenge that it presents to our way of life. MDPI 2020-12-30 /pmc/articles/PMC7823519/ /pubmed/33396667 http://dx.doi.org/10.3390/vaccines9010015 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mahmood, Nasir
Nasir, Sarah Bushra
Hefferon, Kathleen
Plant-Based Drugs and Vaccines for COVID-19
title Plant-Based Drugs and Vaccines for COVID-19
title_full Plant-Based Drugs and Vaccines for COVID-19
title_fullStr Plant-Based Drugs and Vaccines for COVID-19
title_full_unstemmed Plant-Based Drugs and Vaccines for COVID-19
title_short Plant-Based Drugs and Vaccines for COVID-19
title_sort plant-based drugs and vaccines for covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823519/
https://www.ncbi.nlm.nih.gov/pubmed/33396667
http://dx.doi.org/10.3390/vaccines9010015
work_keys_str_mv AT mahmoodnasir plantbaseddrugsandvaccinesforcovid19
AT nasirsarahbushra plantbaseddrugsandvaccinesforcovid19
AT hefferonkathleen plantbaseddrugsandvaccinesforcovid19